Forensics gone wrong: When DNA snares the innocent
By Douglas Starr,
Science/AAAS
| 03. 07. 2016
On a Tuesday morning in Boise, biologist Greg Hampikian is on speakerphone with Christopher Tapp, an inmate at the Idaho State Correctional Institution. Tapp is in prison for a murder he swears he did not commit. Many others think he’s innocent as well—lawyers, journalists, an organization of former judges; even the victim’s mother. No one has fought for him longer than Hampikian, a researcher at Boise State University (BSU). “How’re you doing, Chris?” Hampikian begins. “I’m having a good time at summer camp,” Tapp says gamely. “Although you know me … I’m in the hole again”—solitary. “There was a mutual misunderstanding between me and someone else.” He mentions that he and his wife are getting divorced.
“I’m really sorry Chris, that’s a lot to deal with,” Hampikian says. “You know my offer still stands. I’ll pay tuition for any courses you want to take.” A pause. “You know we got a decision from the court to move forward with a new DNA test. But the court is only allowing us a limited amount and we have to decide which test is...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...